CAPS Human

Calcyphosine Human Recombinant
Shipped with Ice Packs
In Stock

Description

Compound Action Potentials (CAPs) in Human Neurophysiology

CAPs represent synchronized electrical activity in neural or muscular tissues, often measured in auditory and neurological research.

Research Applications

ApplicationMechanismFindings
Auditory Nerve AssessmentConvolution of unit response (UR) with population firing ratesComputational models accurately simulate human CAPs for clicks, chirps, and modulated carriers .
Hearing Disorder DiagnosisNarrowband CAP analysis via noise-masked clicksModels predict spectral/temporal CAP features, aiding in detecting auditory synaptopathy .
Surgical MonitoringIntraoperative CAP recordingCAP morphology changes correlate with auditory nerve integrity during procedures .

Computational Modeling Advances

  • Human CAP Simulation: Integrates post-stimulus time histograms (PSTHs) and URs to replicate empirical data .

  • Clinical Relevance: Accurately predicts effects of hearing loss and neural desynchronization .

CAPS Buffer in Human Biochemical Research

CAPS (3-(Cyclohexylamino)-1-propanesulfonic acid) is a buffering agent used in biochemical assays involving human samples.

Properties and Applications

  • pH Range: 9.7–11.1, ideal for alkaline enzymatic reactions .

  • Common Uses: Protein electrophoresis, Western blotting, and molecular biology protocols .

CAPS in Genetic and Medical Research

  • Genetic Diversity Markers: CAPS markers (derived from SNPs) assess population structure in human genomic studies, with allele frequencies (MAF: 0.524–0.817) and gene diversity (GD: 0.299–0.499) .

  • HIV Research Funding: CAPS grants support pilot studies on HIV prevention/treatment in high-risk populations (e.g., $50k awards for early-stage investigators) .

Data Synthesis

ParameterCAPs (Neurophysiology)CAPS (Buffer)
Primary UseNeural signal analysisBiochemical pH stabilization
Key MetricsAmplitude, latencypKa = 10.4
Human StudiesAuditory diagnostics Protein analysis

Product Specs

Introduction
Calcyphosine (CAPS) is a calcium-binding protein that plays a role in regulating ion transport. It contains four EF-hand domains and is found in various tissues, including epithelial cells and some central nervous system cells. CAPS was first discovered in thyroid follicular cells, where it is synthesized and phosphorylated in response to thyrotropin and cAMP agonists.
Description
Recombinant human CAPS protein is produced in E. coli and is fused to a 20 amino acid His tag at the N-terminus. This results in a single, non-glycosylated polypeptide chain containing 209 amino acids (residues 1-189 of the CAPS protein) with a molecular weight of 23.1 kDa. The protein is purified using proprietary chromatographic methods.
Physical Appearance
Clear, colorless, and sterile-filtered solution.
Formulation
The CAPS protein is supplied as a 1 mg/ml solution in 20mM Tris-HCl buffer (pH 8.0), 10% glycerol, 2mM DTT, and 100mM NaCl.
Stability
For short-term storage (up to 4 weeks), the CAPS protein can be stored at 4°C. For long-term storage, it is recommended to store the protein at -20°C. Adding a carrier protein such as 0.1% HSA or BSA is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
The purity of the CAPS protein is greater than 95% as determined by SDS-PAGE analysis.
Synonyms
Calcyphosin, Calcyphosine, CAPS, CAPS1, MGC126562.
Source
Escherichia Coli.
Amino Acid Sequence

MGSSHHHHHH SSGLVPRGSH MDAVDATMEK LRAQCLSRGA SGIQGLARFF RQLDRDGSRS LDADEFRQGL AKLGLVLDQA EAEGVCRKWD RNGSGTLDLE EFLRALRPPM SQAREAVIAA AFAKLDRSGD GVVTVDDLRG VYSGRAHPKV RSGEWTEDEV LRRFLDNFDS SEKDGQVTLA EFQDYYSGVS ASMNTDEEFV AMMTSAWQL.

Q&A

What is the mathematical foundation of human CAP modeling?

The human CAP is mathematically conceptualized as the convolution of a unit response (UR) waveform with the firing rate of a population of auditory nerve (AN) fibers. This relationship can be expressed as:

CAP(t) = ∫ PPSTH(τ) · UR(t - τ) dτ

where t denotes time, τ is an integration variable, PPSTH is the population post-stimulus time histogram, and UR represents the waveform of the volume-conducted response resulting from a single-unit action potential, as observed from the recording electrode site . This convolution model provides the mathematical framework for predicting experimentally recorded CAPs in humans across various acoustic stimuli.

How do researchers interpret CAP morphology changes with stimulus intensity?

Increasing stimulus intensity produces systematic changes in CAP morphology that reveal underlying physiological mechanisms. As intensity increases:

  • CAP amplitudes increase and latencies decrease

  • Peripheral auditory filters broaden, recruiting higher frequency fibers from the cochlear base

  • Neural synchrony increases across the population response

  • Earlier first-spike latencies emerge in the summed response

Individual differences in the rate of amplitude and peak latency changes with increasing level may reflect variations in the recruitment of low-spontaneous rate (low-SR) fibers. Subjects who recruit relatively more fibers with increasing level typically display steeper amplitude-intensity functions with broader responses yielding prolonged peak latencies . This pattern allows researchers to distinguish between different auditory processing capabilities even among subjects with similar audiometric thresholds.

What novel metrics can be derived from CAP responses to assess auditory nerve function?

Several complementary metrics have been developed to characterize auditory nerve function non-invasively:

  • Response timing metrics: Measurements examining how peak latency shifts with intensity level

  • Neural synchrony indicators: Assessments based on the width of the averaged response

  • Fiber recruitment profiles: Analyses of high-SR versus low-SR fiber contributions based on response patterns

  • Conduction velocity measures: Calculations derived from timing differences across the response

  • Dynamic range assessments: Evaluations of how CAP amplitude grows with increasing stimulus level

These metrics exploit known differences in response patterns between fiber types with different spontaneous rates, conduction velocities, and first-spike latencies . When combined, they provide a multi-dimensional assessment of auditory nerve integrity that can detect subtle dysfunction not apparent in conventional audiometric testing.

What experimental approaches maximize the information value of human CAP measurements?

To obtain maximum diagnostic value from CAP measurements, researchers should implement:

  • Stimulus variety: Employ diverse acoustic stimuli including clicks, chirps, and amplitude-modulated carriers to activate different neural populations

  • Level functions: Record responses across a wide intensity range (typically 20-90 dB) to assess recruitment patterns

  • Masking paradigms: Utilize noise-masking techniques to isolate responses from specific frequency regions

  • Comparative analysis: Examine relationships between multiple response metrics rather than relying on single measures

  • Control populations: Include subjects with varying hearing histories despite similar audiometric profiles

This comprehensive approach allows researchers to characterize neural synchrony and AN fiber recruitment patterns that may differ with noise exposure history even in younger adults with normal pure-tone thresholds .

How should quasi-experimental designs be implemented in human CAP research?

When randomized controlled trials are not feasible or ethical in CAP research, quasi-experimental designs offer robust alternatives:

Design TypeImplementation StrategyStrengthsLimitations
Nonequivalent control groupPre-designate comparison groups matched on critical variablesMaintains comparison frameworkCannot ensure full group equivalence
Before-and-afterUse subjects as their own controls with pre/post measurementsControls for individual variationNo external comparison group
Ex post facto controlDesignate control groups after intervention based on comparable characteristicsAllows for naturalistic observationHigher risk of selection bias

What control variables are essential when investigating CAP differences between populations?

When comparing CAP responses between different populations, researchers must control for:

  • Age-related factors: Neural synchrony and conduction velocity naturally change with age

  • Audiometric profile: Even within "normal" hearing ranges, minor threshold differences can affect CAPs

  • Noise exposure history: Documented lifetime exposure to damaging noise levels

  • Gender differences: Sex-based variations in auditory processing

  • Testing conditions: Time of day, alertness level, and recording environment

  • Medication effects: Substances that might affect neural conduction or cochlear function

Careful documentation of these variables allows for more accurate interpretation of between-group differences and reduces the risk of attributing variations to the wrong causal factors .

How can computational modeling resolve contradictions in human CAP data interpretation?

Computational modeling provides a framework for resolving apparent contradictions in CAP data by:

This approach has successfully simulated CAPs elicited by various stimuli that match empirically recorded responses from human subjects, capturing morphological, temporal, and spectral characteristics . The model-based approach is particularly valuable when direct physiological measurements are impossible in human subjects.

What statistical techniques best address individual variability in CAP measurements?

Given the high individual variability in human CAP responses, optimal statistical approaches include:

  • Within-subject designs: Using each subject as their own control to minimize the impact of individual differences

  • Mixed-effects modeling: Accounting for both fixed effects (experimental conditions) and random effects (subject-specific variations)

  • Multivariate analysis: Examining relationships between multiple CAP metrics simultaneously

  • Bootstrapping techniques: Estimating confidence intervals for parameters with non-normal distributions

  • Classification algorithms: Using machine learning to identify patterns across multiple metrics that may distinguish between normal and pathological conditions

These approaches can more effectively characterize the complex multidimensional nature of CAP responses while accounting for inherent biological variability between subjects .

What methodological frameworks ensure successful Community-Academic Partnerships?

Effective CAPs require structured methodological approaches:

  • Engagement protocol: Establish clear guidelines for partner involvement, decision-making authority, and communication channels

  • Resource mapping: Document resources each partner brings and how they'll be shared

  • Knowledge co-creation: Implement processes for combining academic expertise with community experiential knowledge

  • Evaluation framework: Develop metrics to assess partnership functioning and impact

  • Implementation monitoring: Track how decisions at planning levels translate to ground-level execution

These frameworks help overcome common partnership challenges and ensure that community expertise is valued alongside academic contributions .

How can researchers evaluate CAP implementation effectiveness?

A multi-method evaluation approach for CAPs includes:

  • Content analysis of documentation: Analyzing meeting minutes and communications to identify key decision points and implementation challenges

  • Member checking: Validating interpretations with key implementors through structured feedback processes

  • Stakeholder surveys: Collecting systematic feedback about program elements from all participants

  • Comparative analysis: Examining differences between planning intentions and ground-level implementation

  • Outcome mapping: Tracking how partnership decisions influence ultimate program outcomes

This approach revealed in one health intervention study that CAPs improve relevance, sustainability, and uptake of innovations within communities . The evaluation should focus particularly on how partner discussions translate to practical implementation.

What factors predict successful knowledge translation in Community-Academic Partnerships?

Research indicates several predictive factors for successful knowledge translation in CAPs:

  • Bidirectional knowledge exchange: All partners both contribute and receive knowledge

  • Resource complementarity: Partners provide access to different resources that fill mutual gaps

  • Sustainability planning: Early attention to long-term program maintenance

  • Community relevance: Research questions and outcomes directly address community-identified needs

  • Implementation feasibility: Realistic assessment of implementation requirements in real-world settings

These factors help ensure that academic research translates effectively into community practice and that community insights inform academic research priorities .

What diagnostic approaches have proven most effective for CAPS in research protocols?

Comprehensive CAPS diagnosis in research settings requires a multi-faceted approach:

  • Clinical assessment: Identification of characteristic manifestations including atypical urticaria that patients describe as "tight" and/or "warm" rather than pruritic

  • Laboratory evaluation: Measurement of acute-phase proteins including C-reactive protein (CRP) and serum amyloid A (SAA), typically elevated >5x reference range

  • Genetic testing: Sequencing of the NLRP3 gene, with particular attention to exon 3 of the NACHT domain where mutations predominantly localize

  • Serial measurements: Repeated assessment of inflammatory markers, as normal levels are rarely seen in CAPS

  • Cerebrospinal fluid analysis: For patients with neurological symptoms, particularly those with NOMID

Importantly, research has identified CAPS patients without detectable NLRP3 mutations who present with clinical manifestations very similar to those with mutations, suggesting the importance of comprehensive sequencing beyond commercially available tests that only target exon 3 .

How do experimental treatment protocols evaluate therapeutic efficacy in CAPS?

Research protocols for evaluating CAPS treatments typically implement:

  • Biomarker monitoring: Monthly measurements of CRP/SAA levels to assess systemic inflammation

  • Symptom documentation: Systematic recording of clinical manifestations including rash, neurological symptoms, and joint involvement

  • Dose-response assessment: Evaluation of efficacy at different dosage levels, starting with standard doses and potentially reducing to determine minimum effective levels

  • Treatment interruption challenges: Brief, monitored discontinuation of treatment to assess symptom recurrence timeline

  • Long-term outcome tracking: Monitoring for complications such as amyloidosis and progressive hearing loss

In one study examining anakinra treatment, all 15 treated patients showed complete remission within 12 hours of injection, with normalization of inflammatory markers after one week. When treatment was briefly interrupted, symptoms reappeared within 36-48 hours, providing strong evidence for daily administration requirements .

What molecular mechanisms explain CAPS pathophysiology and treatment response?

The current understanding of CAPS pathophysiology centers on:

  • Inflammasome dysregulation: Gain-of-function mutations in NLRP3 lead to constitutive activation of inflammasomes

  • IL-1β overproduction: Activated inflammasomes induce excessive IL-1β production, driving systemic inflammation

  • Cellular expression patterns: Cryopyrin is expressed in monocytes, neutrophils, and human chondrocytes, explaining the diverse manifestations including arthropathy

  • Redox homeostasis disruption: Monocytes from CAPS patients show impaired redox homeostasis and response to oxidative stress

  • Treatment mechanisms: IL-1 blockade directly targets the downstream effects of inflammasome hyperactivation

This mechanistic understanding explains why IL-1 blocking agents are effective and helps predict which patients might benefit most from treatment . The success of these targeted therapies provides further confirmation of the central role of IL-1β in CAPS pathogenesis.

How can researchers overcome barriers to interdisciplinary collaboration in CAPS research?

Effective interdisciplinary collaboration requires addressing common barriers:

  • Terminology alignment: Develop shared definitions when the same acronym (CAPS) refers to different research domains

  • Methodological translation: Create frameworks for integrating different research approaches

  • Expertise recognition: Acknowledge the value of diverse expertise across disciplines

  • Collaborative planning: Involve multiple disciplines in study design from the outset

  • Communication platforms: Establish regular communication channels designed for interdisciplinary exchange

Research shows that people often underestimate others' willingness to help, with fears about appearing incompetent or burdening others preventing collaborative requests . Creating structured opportunities for cross-disciplinary engagement can overcome these psychological barriers.

What statistical approaches address data heterogeneity challenges in CAPS research?

When dealing with heterogeneous data across CAPS studies:

These techniques help researchers extract meaningful insights from complex, multifaceted data while appropriately acknowledging limitations and uncertainty.

Product Science Overview

Gene and Protein Structure

The CAPS gene encodes the calcyphosine protein, which contains four EF-hand domains, typical of calcium-binding proteins . The gene is located on chromosome 19 in humans and has several aliases, including CAPS1 and MGC126562 .

Function and Mechanism

Calcyphosine is involved in the regulation of ion transport. In thyroid follicular cells, it is synthesized and phosphorylated in response to stimulation by thyrotropin and cAMP agonists . This protein may play a role in various cellular signaling pathways, although its exact mechanisms are still under investigation.

Recombinant Calcyphosine

Recombinant human calcyphosine is produced using Escherichia coli (E. coli) expression systems. The recombinant protein typically includes an N-terminal His-tag to facilitate purification . It is used in various research applications, including studies on calcium-binding proteins and their roles in cellular processes.

Clinical and Research Applications

Calcyphosine has been associated with several diseases, including bone resorption disease and giant papillary conjunctivitis . Its role in these conditions is still being explored, but its involvement in calcium signaling makes it a protein of interest in both clinical and research settings.

Summary

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.